Hello, Thanks for signing up for MarketBeat Daily Ratings—we’re excited to have you on board. Every weekday, you’ll get a curated summary of new “Buy” and “Sell” ratings from Wall Street’s top-rated analysts, the latest stock news, and bonus investing content—all delivered straight to your inbox. You’re just two quick steps away from completing your sign-up: 1. Make sure our emails go to your inboxGmail users:
Mobile: Tap the three dots (…) in the top right and select Move to Inbox or Move to Primary
Desktop: Click the folder icon at the top and select Move to Inbox or Primary Apple Mail users:
Tap our email address at the top (next to From: on mobile), then select Add to VIP Other providers:
Reply to this message and add newsletters@analystratings.net to your contacts 2. Confirm your subscriptionClick this link to confirm your subscription. This verifies your account and ensures you receive your newsletters without interruption instead of getting stuck in your spam filter. Confirm your subscription here. After you confirm, feel free to download our popular free report, "7 Stocks to Buy and Hold Forever" with this link. Thanks again for subscribing—we look forward to being part of your investing journey. 
Matthew Paulson
Founder and CEO, MarketBeat. P.S. If you didn’t mean to subscribe, no problem—you can unsubscribe here.
This Week's Exclusive Content
Procter & Gamble Gave the Market What It Wanted: A Reason to BuyReported by Thomas Hughes. Article Posted: 4/24/2026. 
Key Points
- Procter & Gamble had a better-than-expected quarter, alleviating fears and providing a reason to buy.
- Cash flow and capital return remain strong, giving investors leverage.
- Analysts and institutions underpin the rebound; how high it gets depends on how long you hold it.
- Special Report: Have $500? Invest in Elon’s AI Masterplan
Procter & Gamble (NYSE: PG) is a high-quality consumer-staples and home-products company with a long track record of cash flow and capital returns. It's a classic buy-and-hold stock—ideal for income and dividend compounding—but its share price struggled in 2026 amid concerns about tariff impacts, foreign-exchange headwinds, margins and cash flow. Those worries produced volatility and a sharp March correction. After the fiscal Q3 results in late April, however, the takeaway is that fears were overblown: the market overreacted, and shares are trading near long-term lows, creating a buying opportunity. Procter & Gamble Navigates Hurdles: Reinvigorates Market InterestProcter & Gamble had a solid quarter, extending growth driven by both organic trends and acquisitions. Net revenue of $21.24 billion rose 7.3% year over year (YOY), roughly 350 basis points ahead of consensus.
For a moment…
Forget about Trump’s ties to Israel.
Forget about reports of Iran’s nuclear program.
Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason. Click here to find out what it is.
Organic sales grew 3%, composed of a 2% volume increase and a 1% price contribution, with strength across all segments. Beauty led with 7% growth, while Grooming was the laggard at 1%, yet consumer resilience remained evident. Earnings were another bright spot. The company faced tariff-related and other headwinds but partly offset them with price increases, efficiency gains and a favorable foreign-exchange tailwind. The results produced roughly $4 billion in earnings and $4 billion in operating cash flow, with an 82% cash flow productivity (free cash flow conversion) metric. Free cash flow of $3.28 billion comfortably covered capital returns—dividends and share repurchases—totaling $3.2 billion. Procter & Gamble’s capital returns are notable for their size, consistency and growth. The company is a Dividend King, having increased its distribution annually for 70 years, and it maintains a sustainable mid-single-digit compound annual growth rate (CAGR) in its payout. Management continues to expect modest single-digit revenue growth and sufficient earnings to support capital returns and its financial health. The results imply the pace of dividend increases and share buybacks should persist. Buybacks matter because P&G has aggressively reduced its share count, which offsets the effect of dividend hikes and supports the distribution CAGR. During fiscal Q3 the diluted share count fell about 1.35% year over year, and the dividend yield is nearly 3% with shares trading near the low end of their historical P/E range. Analysts and Institutions Underpin Procter & Gamble Stock Price ReboundAnalysts played a role in PG’s 2026 price decline by issuing a series of price-target cuts. Those reductions, however, appear to price in the downside; the late-April consensus points to a modest double-digit gain from the critical support level. Given the better-than-expected report and guidance, analyst sentiment may firm, which would help strengthen the price floor. The low end of analysts' target range sits near $142—close to the Q1 lows and an important support level—while consensus places the stock above a cluster of moving averages and back into rally territory. Institutions are potential buyers of the recent dip. The group owns more than 65% of the stock and has accumulated at about a $2-to-$1 pace on a trailing 12-month basis. Institutional activity ramped in 2025 as price action weakened, and it was a factor in January 2026 when the stock touched critical levels and rebounded nearly 20%. The risk now is that some institutions began selling in early Q2 and may not participate in the rebound. With the AI trade back in full force and attracting capital across markets, institutions could refocus on tech and continue trimming PG positions. Technical Setup: A Rebound With Resistance OverheadThe technical signals show unusual volatility for a classic buy-and-hold stock, but they also indicate a solid price floor that has triggered multiple rebounds over the years. The mid-Q2 setup suggests another rebound with potential upside of $15 to $20, but there is clear risk: resistance at the 150-day exponential moving average (EMA) could cap gains. The 150-day EMA represents the behavior of long-term investors, including institutions, and current data suggest some of those holders have been selling. If the market cannot clear this level, a sustained rebound is less likely until later in the year. 
The long-term price outlook remains constructive. With shares trading near the low end of the historical P/E range, valuation alone could support roughly a 50% gain. Combine that with modest organic growth, and PG could look even cheaper—suggesting as much as 100% upside for patient, long-term investors who buy and hold. |
0 Response to "We're excited to have you on board"
Post a Comment